{"anticipatedPostingDate":"2026-08","denomUnitsSelected":"Participants","description":"To evaluate the duration of overall survival achieved with physician's choice selinexor-based combination therapy.","reportingStatus":"NOT_POSTED","timeFrame":"EOT + 2 years, or date of progression (whichever comes first)","title":"Overall Survival","type":"SECONDARY"}